PP 22 Analysis of HER-3, insulin-growth factor-1 (IGF-1), nuclear factor k-B (NF-kB) and epidermal growth factor receptor (EGFR) gene copy number (GCN) in the prediction of clinical outcome for K-RAS wild type colorectal cancer patients receiving irinotecan–cetuximab
暂无分享,去创建一个
E. Maccaroni | S. Cascinu | E. Galizia | L. Giustini | A. Falcone | M. Scartozzi | R. Giampieri | A. Mandolesi | I. Bearzi | R. Silva